Ventripoint Diagnostics Ltd. (TSXV:VPT)
0.1200
-0.0050 (-4.00%)
At close: Feb 9, 2026
Ventripoint Diagnostics Revenue
Ventripoint Diagnostics had revenue of 168.08K CAD in the twelve months ending June 30, 2025, up 133.23% year-over-year. In the year 2024, Ventripoint Diagnostics had annual revenue of 95.17K with 93.51% growth.
Revenue (ttm)
168.08K
Revenue Growth
+133.23%
P/S Ratio
124.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 95.17K | 45.99K | 93.51% |
| Dec 31, 2023 | 49.18K | -18.98K | -27.85% |
| Dec 31, 2022 | 68.17K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 36.02K | -45.01K | -55.55% |
| Dec 31, 2019 | 81.02K | 20.85K | 34.64% |
| Dec 31, 2018 | 60.18K | 21.27K | 54.68% |
| Dec 31, 2017 | 38.91K | -170.57K | -81.43% |
| Dec 31, 2016 | 209.48K | 158.18K | 308.38% |
| Dec 31, 2015 | 51.30K | -77.16K | -60.07% |
| Dec 31, 2014 | 128.45K | 57.51K | 81.05% |
| Dec 31, 2013 | 70.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.14M |
| Conavi Medical | 9.12M |
| Perimeter Medical Imaging AI | 2.78M |
| Cheelcare | 1.56M |
| Frequency Exchange | 1.12M |
| Theralase Technologies | 1.00M |
| NuGen Medical Devices | 589.43K |
| MedX Health | 522.90K |
Ventripoint Diagnostics News
- 12 days ago - Ventripoint Issues Shares for Debt Settlement and Awards Option Grants - TheNewswire
- 13 days ago - AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market - Benzinga
- 21 days ago - Ventripoint Announces Closing of Non-Brokered Units Private Placement - TheNewswire
- 24 days ago - Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
- 24 days ago - Ventripoint Issues Shares for Payment of Debenture Interest - TheNewswire
- 4 weeks ago - Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand - TheNewswire
- 5 weeks ago - Ventripoint Announces Non-Brokered Units Private Placement - TheNewswire
- 7 weeks ago - Ventripoint Diagnostics Announces Collaboration with Summit Sciences - TheNewswire